bringing evidence into dju-lyn chng 茹玲 account development manager
DESCRIPTION
Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager. What will we cover today?. What is Evidence-Based Medicine? Why is EBM important? What is the traditional method of practicing EBM? How Clinical Evidence fits into the practice of EBM? Case Scenario. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/1.jpg)
Bringing Evidence intoDju-Lyn Chng 茹玲Account Development Manager
![Page 2: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/2.jpg)
What will we cover today?
• What is Evidence-Based Medicine?• Why is EBM important?• What is the traditional method of
practicing EBM?• How Clinical Evidence fits into the practice
of EBM?
• Case Scenario
![Page 3: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/3.jpg)
What is evidence based medicine?
“Evidence based medicine is the “conscientious, explicit and judicious use of current best evidence in making decisions about individual patients”.
Sackett DL et al 1996
![Page 4: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/4.jpg)
Patient values
Patientcircumstances
Clinicalexpertise
Best research evidence
EBM
Evidence-based Medicine: How to teach and practice EBM. Straus SE, Richardson WS, Paul Glasziou, Haynes RB. Third Edition. Churchill Livingston: Edinburgh, 2005.
Evidence Based
Medicine
![Page 5: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/5.jpg)
What is not evidence based medicine?
Evidence based medicine does not tell healthcare professionals what to do.
Evidence based medicine identifies management options, and how well they are supported by evidence in defined populations.
![Page 6: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/6.jpg)
Why is evidence based medicine important?
Evidence based medicine allows healthcare professionals to:
• Identify gaps in knowledge• Choose effective treatments• Choose between effective treatments• Choose cost-effective treatments
• Stop using treatments that do not work and / or that harm patients
![Page 7: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/7.jpg)
Different levels of evidence – The Haynes Pyramid
Systems
Summaries
Synopses
Syntheses
Studies
Examples
Computerized decision support
Evidence-based textbooks
Evidence-based journal abstracts
Systematic reviews
Original journal articles
The evolution of Evidence-Basedinformation systems
More time is needed as we go down the pyramid
R Brian Haynes. Of studies, syntheses, synopses, summaries, and systems: the "5S" evolution of information services for evidence-based healthcare decisions. Evidence-Based Medicine 2006;11:162-164.
![Page 8: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/8.jpg)
PubMed: Studies: 原始研究文獻
![Page 9: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/9.jpg)
海量的醫學文獻• 8000 articles published per day
• 30 kg of guidelines per family doctor
• 25,000 biomedical journals in print
• 1500 medical articles onto Medline per day
![Page 10: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/10.jpg)
Cochrane systematic reviews: Syntheses: 系統性綜述
![Page 11: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/11.jpg)
Evidence based medicine journal: Synopses: 單篇循證文獻摘要性評述
![Page 12: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/12.jpg)
BMJ Clinical Evidence: Summaries: 針對臨床問題結合證據的概述
![Page 13: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/13.jpg)
What is BMJ Clinical Evidence?Helping Clinicians Put Evidence Into Practice
Features
• Provides systematic reviews offering evidence on over 3,100 interventions in over 650 clinical situations
• Includes evidence based research sources from over 10,000 peer reviewed articles from Cochrane Library, Medline, Embase and evidence based journals
• Produced by international panel of clinicians using rigorous searching and evaluation methods
• Summary of the best evidence of benefits and harms of interventions
• Updated regularly
• Links to abstracts on PubMed
![Page 14: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/14.jpg)
實證醫學的五個主要步驟• Assess• Ask clinical question
提出一個可以被回答的問題• Acquire the evidence
檢索文獻資料 • Appraise the evidence
嚴格評價證據的可信度和相關性• Apply the evidence
結合實際作出臨床決策
![Page 15: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/15.jpg)
Traditional Steps of Evidence Based Medicine
• Assess • Ask clinical question• Acquire the evidence• Appraise the evidence• Apply the evidence
![Page 16: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/16.jpg)
How BMJ Clinical Evidence relates to the steps of EBM?
•“Ask clinical questions”•Review planning
•“Acquire the Evidence”
•Appraise the evidence
•“Apply the Evidence”•Combined into structured summaries
![Page 17: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/17.jpg)
Planning – Ask clinical questions...• PICOT
– Patient – Intervention/Risk factor – Comparison – Outcome
– Type of Study (Systematic reviews? RCTs?)
• Quality parameters– Size of study– Length of follow up– Loss to follow up
![Page 18: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/18.jpg)
Searching – Acquire the evidence...
• PubMed• Medline• Cochrane Reviews• Embase• … and many more
![Page 19: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/19.jpg)
Searching – Acquire the evidence...
![Page 20: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/20.jpg)
Searching – Evidence for benefits of a treatment... But... What about the harms?
• Systematic reviews often do not search for adverse effects (Ernst 2001)
• RCTs are not big enough or long enough to detect many harms
• Published trials including harms data can be difficult to find (Derry 2001)
• Many observational studies to appraise
![Page 21: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/21.jpg)
How BMJ Clinical Evidence search for harms
• Look for specific adverse effects identified at review planning
• Decide which type of evidence will be appropriate
• RCTs – for expected and common harms that happen soon after treatment
• Unexpected, rare and delayed harms may require case-control/cohort search
![Page 22: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/22.jpg)
Displaying the Benefits and Harms
![Page 23: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/23.jpg)
Information categorised
![Page 24: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/24.jpg)
Detailed evidence for each treatment
![Page 25: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/25.jpg)
Benefits
![Page 26: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/26.jpg)
Harms
![Page 27: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/27.jpg)
Appraisal – appraise the evidence…BMJ Clinical Evidence appraisal criteria
![Page 28: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/28.jpg)
Appraisal – Selection of studies
DO YOU WANT TO INCLUDE THIS ARTICLE? YES NO IF NO, INDICATE REASON FOR EXCLUSION BELOW:Irrelevant/wrong question Not RCTNot Blinded Wrong comparison Too small Wrong intervention Wrong patient group Surrogate Outcome Less than 80% follow upOther (please specify)..........................................................
![Page 29: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/29.jpg)
![Page 30: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/30.jpg)
Appraisal – BMJ Clinical Evidence
makes the GRADE
![Page 31: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/31.jpg)
What is GRADE?
• Grading of • Recommendations • Assessment, • Development and • Evaluation system for grading evidence
![Page 32: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/32.jpg)
What is GRADE?
• Developed by international guideline developers
• Explicit evaluation of the importance of outcomes
• Explicit, comprehensive criteria for downgrading and upgrading quality of evidence ratings
• Clear separation between quality of evidence and strength of recommendations
![Page 33: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/33.jpg)
GRADE categorisations – Quality of Evidence
High: • Further research is very unlikely to change our confidence
in the estimate of effect.Moderate:
• Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low: • Further research is very likely to have an important impact
on our confidence in the estimate of effect and is likely to change the estimate.
Very low: • Any estimate of effect is very uncertain.
![Page 34: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/34.jpg)
GRADE – Strength of recommendations
Strong– desirable effects clearly outweigh
undesirable effects, or the reverse – Most patients will make same decision
about the treatment
Weak – different patients will choose different
approaches to treatment
![Page 35: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/35.jpg)
What GRADE version of CE looks like• Summary
statements rewritten
• Glossary links explain what GRADE scores mean
• Links to GRADE table from each summary statement
Glossary
GRADE Table
![Page 36: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/36.jpg)
GRADE Table
• Transparent explanation for why points were added/deducted
• Linked to relevant references
![Page 37: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/37.jpg)
Scoring system
![Page 38: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/38.jpg)
Planning
Appraisal
Publish
Searching
BMJ Clinical Evidence Updating Cycle
Does it stop here?
– Repeated every 6 to 12 months
– Updated regularly
![Page 39: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/39.jpg)
BMJ Updates
Collaboration with McMaster University
Engages over 3,000 clinicians
Systematic survey of over 120 top clinical journals
![Page 40: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/40.jpg)
![Page 41: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/41.jpg)
Guidelines
![Page 42: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/42.jpg)
![Page 43: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/43.jpg)
• What feature in Clinical Evidence will help you determine the quality of an evidence?
Pop Quiz 1:
•Answer: The GRADE Table
![Page 44: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/44.jpg)
Looking back – Traditional Steps of Evidence Based Medicine
• Assess • Ask clinical question• Acquire the
evidence• Appraise the
evidence• Apply the evidence
Systems
Summaries
Synopses
Syntheses
Studies
Examples
Computerized decision support
Evidence-based textbooks
Evidence-based journal abstracts
Systematic reviews
Original journal articles
The evolution of Evidence-Basedinformation systems
![Page 45: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/45.jpg)
What makes a good EBM Summary Database?
• Comprehensive literature search• Pre-appraised
– Appraisal methods– Based around clinical questions and patient outcomes– Inclusion and Exclusion criteria– Preference for systematic reviews over individual studies
• Regularly updated• Easy access and use• Links to original paper
![Page 46: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/46.jpg)
Does BMJ Clinical Evidence “fit the bill”?Comprehensive literature searchPre-appraised
Appraisal methods Based around clinical questions and patient
outcomes Inclusion and Exclusion criteria Preference for systematic reviews over individual
studies Regularly updatedLinks to original paper• Easy access and use
![Page 47: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/47.jpg)
Case Scenario:• You are an inexperienced junior hospital doctor. A 55 year old asthmatic
man who has heart failure attends the out-patient clinic. Despite taking an ACE inhibitor his heart failure is inadequately controlled. You discuss the case with your senior who advises that you add an Angiotensin II reception blocker to his treatment.
• 你是一名年輕的臨床醫生,接診一名 55 嵗男性氣喘者,同時患有心力衰竭。儘管服用血管緊張素轉化酶抑制劑 (ACE Inhibitor) ,但效果不明顯。你的資深同事建議加入血管緊張素 II 受体拮抗劑 (Angiotensin II Reception Blocker) 治療。
• You are worried, having never combined these two types of drugs before, and would like reassurance that this is a reasonable course of action…
• 你擔心自己從沒有混合使用兩种藥物的先例,故希望找到可靠的證據。。。
![Page 48: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/48.jpg)
Where do we start?
![Page 49: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/49.jpg)
![Page 50: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/50.jpg)
![Page 51: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/51.jpg)
![Page 52: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/52.jpg)
![Page 53: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/53.jpg)
![Page 54: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/54.jpg)
![Page 55: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/55.jpg)
Does BMJ Clinical Evidence “fit the bill”?Comprehensive literature searchPre-appraised
Appraisal methods Based around clinical questions and patient
outcomes Inclusion and Exclusion criteria Preference for systematic reviews over individual
studies Regularly updatedLinks to original paperEasy access and use
![Page 56: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/56.jpg)
• Which of the following are features of Clinical Evidence?A. Covers the benefits and harms of each
interventionB. Summarises the condition based on key
questions asked by clinicians, summary and background of the condition
C. Produced by an international panel of clinicians using rigorous searching and evaluation methods
D. All of the above
Pop Quiz 2:
![Page 57: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/57.jpg)
![Page 58: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/58.jpg)
New and Upcoming!- New BMJ Evidence Centre- Upcoming BMJ Best Practice
![Page 59: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/59.jpg)
The New BMJ Evidence CentreThe new hub of evidence-based medicine…http://group.bmj.com/products/evidence-centre
![Page 60: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/60.jpg)
![Page 61: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/61.jpg)
![Page 62: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/62.jpg)
New in January 2009
![Page 63: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/63.jpg)
What is BMJ Best Practice ?
• Point of Care tool / Decision Support tool• Combination of Evidence, Expert Opinion and
Guidelines• Common conditions primary & secondary care• Structured and set by step approach• Summary, Basic / Background Info, Prevention,
Diagnosis, Treatments, Evidence, Drugs, follow up & patient info
![Page 64: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/64.jpg)
Key Features:• In-depth coverage of 1000 conditions1
• Action-oriented and structured around the patient consultation
• Advice on symptom evaluation, treatment approach and test ordering
• International perspective, customisable for local needs• Integrated evidence from Clinical Evidence• Critical prescribing information with links to local drug
formulary• Guideline summaries and expert opinion • 192 patient support leaflets• Open URL Compliant
1At launch in January 2009, Best Practice will feature 500 conditions. These will be added to during the course of the year with more than 1000 conditions available by December 2009.
![Page 65: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/65.jpg)
Evidence
![Page 66: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/66.jpg)
![Page 67: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/67.jpg)
Evidence > Intervention Table
![Page 68: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/68.jpg)
Condition Overviews
![Page 69: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/69.jpg)
Differential Diagnosis
![Page 70: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/70.jpg)
Step-by-Step (Diagnostic Approach)
![Page 71: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/71.jpg)
Step-by-Step (Treatment Approach)
![Page 72: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/72.jpg)
Images
![Page 73: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/73.jpg)
My Best Practice
![Page 74: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager](https://reader033.vdocuments.site/reader033/viewer/2022050702/56815a6d550346895dc7cc36/html5/thumbnails/74.jpg)
Resource list
• BMJ Clinical Evidence www.clinicalevidence.com• BMJ Updates www.bmjupdates.com• Cochrane Library
www3.interscience.wiley.com/cgi-bin/mrwhome/106568753/HOME?CRETRY=1&SRETRY=0
• PubMed Clinical Queries www.ncbi.nlm.nih.gov/entrez/query/static/clinical.shtml
• National Guidelines Clearing House www.guidelines.gov/• Centre for Evidence based medicine www.cebm.net/index.asp• Centre for Reviews and Dissemination www.york.ac.uk/inst/crd• ScHARR www.shef.ac.uk/scharr/